NCT02733367View on ClinicalTrials.gov

Extension Study for Patients Entered Into Study Infacort 003

PHASE3CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 4, 2016

Primary Completion Date

August 10, 2018

Study Completion Date

August 10, 2018

Conditions
Adrenal Insufficiency
Interventions
DRUG

Infacort®

Infacort® is a dry granule formulation of hydrocortisone stored in capsules available in different strengths (0.5, 1.0, 2.0 and 5.0 mg).

Trial Locations (1)

13353

Charité-Universitätsmedizin Berlin, CVK, Berlin

All Listed Sponsors
lead

Neurocrine UK Limited

INDUSTRY

NCT02733367 - Extension Study for Patients Entered Into Study Infacort 003 | Biotech Hunter | Biotech Hunter